Available In The USA
Endoscopy Supplies EUSRA™ EUS-guided RFA Treatment
Category: RFA Treatment
Details and Features
- Feasible and safe ablative treatment for locally advanced unresectable pancreatic cancer, neuroendocrine tumors, and cystic neoplasms
- Easy approach to target lesions with a great pushability of the needle
- Good echogenicity for safe procedure under EUS-guidance
- Inner cooling system to ablate large volumes of tumor without tissue charring
- A monopolar system
- Compatible with VIVA Combo™ generators ONLY
Pancreatic tumor (locally advanced pancreatic cancer, pancreatic neuroendocrine tumor, pancreatic cysts, etc)
Extra pancreatic tumor (liver, adrenal, kidney, GI gyst, etc)
EUS-guided radiofrequency ablation of the porcine pancreas
Gastrointestinal Endoscopy Vol.76, No.5: 2012 Dong-Wan Seo, MD, PhD
Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer
Gastrointestinal endsocopy 2015 Dong Wan Seo, MD, PhD
EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos)
Gastrointestinal Endsocopy 2015 Sundeep Lakhtakia, MD, DM, MNAMS, FASGE
Endoscopic ultrasound-guided radiofrequency ablation of a pancreatic neuroendocrine tumor
Endsoscopy 2015 Elia Armellini, Stefano F. Crino, Marco Ballare, Pietro Occhipinti, MD, Italy
Electrode radiofrequency ablation EUS-guided-EUSRA™
Giornale Italiano Di Endoscopia Digestiva, Marzo 2017 Elia Armellini et al.
Cushing’s syndrome managed by endoscopic ultrasound-guided radiofrequency ablation of adrenal gland adenoma
Endoscopy 2017;49:E1-E2 Dong Wan Seo, MD, PhD
In the ever-evolving landscape of medical technology, one innovation stands out as a game-changer in the field of endoscopy: EUSRA™ – the Endoscopic Ultrasound-guided Radiofrequency Ablation (EUS-guided RFA) Treatment. This cutting-edge advancement promises a transformative approach to the diagnosis and treatment of various gastrointestinal conditions.
EUSRA™ combines the precision of endoscopic ultrasound with the therapeutic power of radiofrequency ablation to provide a minimally invasive solution for patients dealing with pancreatic cysts, tumors, and other complex gastrointestinal issues. Unlike traditional surgical methods, EUSRA™ offers reduced risk, shorter recovery times, and minimal discomfort.
This groundbreaking technology opens new doors for physicians and patients alike. With its ability to precisely target and treat abnormalities, EUSRA™ enables doctors to make more accurate diagnoses and formulate tailored treatment plans. Patients benefit from quicker procedures, less pain, and a faster return to their daily lives.
As medical science continues to push boundaries, EUSRA™ stands as a testament to human ingenuity, bringing hope to countless individuals facing gastrointestinal challenges. The future of endoscopy is here, and it’s called EUSRA™ – the beacon of progress in the world of medical innovation.